Written by Marija Obradovic || 14th January 2019 || Regulatory reports |
CBD is classed in New Zealand as a medical substance, available only on a doctor’s prescription.
The only part of the hemp plant that can be used in food is the seeds.
Hemp seeds used in food cannot have more than 75 mg/kg (0.0075%) of CBD.
Cosmetics and e-cigarettes must be CBD-free.
Industrial hemp with less than 0.35%-0.5% THC can be cultivated with a licence.
There may be a referendum on recreational cannabis use within the next two years.
...
Restricted content. Do you want to read more?
The Report you have tried to access is restricted to our subscribers, or may not be available in your subscription package. ECigIntelligence Reports contain detailed in-depth analysis on the regulatory landscape or market profile of a particular territory, or are consolidated reports on particular topics or sectors.
Please get in contact to upgrade your package, or to discuss our subscription services in general if you are not yet a subscriber.
Login
If you have an account with us, please log in
Login Here
CBD-Intel provides premium market and regulatory analysis, legal tracking, and quantitative data for the cannabidiol (CBD) sectors, with a focus on non-US markets.
We provide our clients with the tools to navigate this fast-moving sector, tailor their business strategy, optimise resources and make informed decisions.
